Evidence map›Paper›PMID 40326780›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2025

Downregulation of EZH2 Promotes Renal Epithelial Cellular Senescence and Kidney Aging.

Yingying Zhang, Chen Yu, Ewud Agborbesong, Xiaogang Li

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yingying ZhangDepartment of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0001-8245-5866
Chen YuDepartment of Nephrology, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai, China.ORCID https://orcid.org/0000-0001-7169-276X
Ewud AgborbesongDepartment of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Xiaogang LiDepartment of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Funding

The crosstalk of DNA and lysine methyltransferases in ADPKD.R01DK126662 · NIDDK · MAYO CLINIC ROCHESTER · PI Xiaogang Li · 2020 to 2026
$3.0M
ADPKD: Understanding immunosuppression mechanisms and discovering treatmentR01DK129241 · NIDDK · MAYO CLINIC ROCHESTER · PI LI, XIAOGANG · 2021 to 2024
$1.8M
Implementing Pharmacogenomics in Diverse Health Care SystemsR21HG011337 · NHGRI · DUKE UNIVERSITY · PI SPERBER, NINA · 2021 to 2021
$455k
DOD | AF | ATC | 59th Medical Wing (MDW) PR221810NHGRI NIH HHS R21 HG011337NIDDK NIH HHS R01 DK126662NIDDK NIH HHS R01 DK129241
6 · The paper itself

Abstract

Renal epithelial cell senescence and kidney aging have become the focus of scientific investigation. However, how epigenetic regulation in these processes remains elusive. Enhancer of zeste homolog 2 (EZH2), a histone methyltransferase, regulates trimethylation of histone H3 at lysine 27 (H3K27me3) and plays an important role in renal pathophysiology. In this study, we show that the expression of EZH2 is decreased in naturally aged and irradiation (IR)-induced mouse kidneys, as well as in IR-induced human renal cortical tubular epithelial (RCTE) cells through proteasome-mediated degradation. Inhibition of EZH2 with its specific inhibitor 3-DZNeP promotes tubular cell senescence and kidney aging characterized by an increase in the expression of senescence markers, including p16 and p21, in mouse kidneys and in IR-induced RCTE cells. We show that EZH2 represses the transcription of p16 through trimethylation of H3K27me3, which directly binds to the promoter of p16. EZH2 represses the transcription of p21 through directly binding to the promoter of p21, and this process is involved in its interaction with p53 and its phosphorylation by ataxia-telangiectasia mutated (ATM), a critical protein involved in the cellular response to DNA damage. Inhibition of ATM with its inhibitor decreased the phosphorylation of EZH2 and the binding of EZH2 to the promoter of p21 in IR-treated RCTE cells in a p53-dependent manner. This study suggests that EZH2 plays a critical role in preventing kidney aging and DNA-damage-induced renal tubular cellular senescence, in which senescence and kidney aging also result in the destabilization of EZH2, forming a negative feedback loop.

Indexed as

AgingCellular SenescenceDown-RegulationEnhancer of Zeste Homolog 2 ProteinEpithelial CellsKidneyAnimalsCyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase Inhibitor p21HistonesHumansMaleMiceMice, Inbred C57BLTumor Suppressor Protein p53Cyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase Inhibitor p21Enhancer of Zeste Homolog 2 ProteinEZH2 protein, humanEzh2 protein, mouseHistonesTumor Suppressor Protein p53DNA damageenhancer of zeste homolog 2 (EZH2)histone modificationkidney agingsenescence

Identifiers

PMID40326780
PMCPMC12097276

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.